Skip to main content
Top
Published in: Journal of Orthopaedic Science 6/2011

01-11-2011 | Case Report

A compound heterozygous mutation of CYP27A1 gene in a Taiwanese patient with cerebrotendinous xanthomatosis

Authors: Wen-Chau Chen, Kuo-Chen Wu, Chih-Hsiung Hu, Tai-Chang Chern, I-Ming Jou

Published in: Journal of Orthopaedic Science | Issue 6/2011

Login to get access

Excerpt

Cerebrotendinous xanthomatosis (CTX, OMIM: 213700) is a rare inherited autosomal recessive lipid storage disorder with multiple system involvement. The disease is caused by mutations in the gene encoding sterol 27-hydroxylase (CYP27A1), leading to a block in bile synthesis, with accumulation of substrates for this enzyme, including cholesterol, resulting in an increase in the conversion of cholesterol to cholestanol. Clinically, CTX is characterized by tendon xanthomas, juvenile cataracts, premature atherosclerosis, and progressive neurological deficits [1]. We report the mutation analysis of a Taiwanese patient with CTX involving only the Achilles tendon. …
Literature
1.
go back to reference Moghadasian MH, Salen G, Frohlich JJ, Scudamore CH. Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations. Arch Neurol. 2002;59:527–9.PubMedCrossRef Moghadasian MH, Salen G, Frohlich JJ, Scudamore CH. Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations. Arch Neurol. 2002;59:527–9.PubMedCrossRef
2.
go back to reference Nakashima N, Sakai Y, Sakai H, Yanase T, Haji M, Umeda F, Koga S, Hoshita T, Nawata H. A point mutation in the bile acid biosynthetic enzyme sterol 27-hydroxylase in a family with cerebrotendinous xanthomatosis. J Lipid Res. 1994;35:663–8.PubMed Nakashima N, Sakai Y, Sakai H, Yanase T, Haji M, Umeda F, Koga S, Hoshita T, Nawata H. A point mutation in the bile acid biosynthetic enzyme sterol 27-hydroxylase in a family with cerebrotendinous xanthomatosis. J Lipid Res. 1994;35:663–8.PubMed
3.
go back to reference Moghadasian MH. Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds. Clin Invest Med. 2004;27:42–50.PubMed Moghadasian MH. Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds. Clin Invest Med. 2004;27:42–50.PubMed
4.
go back to reference Guyant-Marechal L, Verrips A, Girard C, Wevers RA, Zijlstra F, Sistermans E, Vera P, Campion D, Hannequin D. Unusual cerebrotendinous xanthomatosis with fronto-temporal dementia phenotype. Am J Med Genet. 2005;139A:114–7.PubMedCrossRef Guyant-Marechal L, Verrips A, Girard C, Wevers RA, Zijlstra F, Sistermans E, Vera P, Campion D, Hannequin D. Unusual cerebrotendinous xanthomatosis with fronto-temporal dementia phenotype. Am J Med Genet. 2005;139A:114–7.PubMedCrossRef
Metadata
Title
A compound heterozygous mutation of CYP27A1 gene in a Taiwanese patient with cerebrotendinous xanthomatosis
Authors
Wen-Chau Chen
Kuo-Chen Wu
Chih-Hsiung Hu
Tai-Chang Chern
I-Ming Jou
Publication date
01-11-2011
Publisher
Springer Japan
Published in
Journal of Orthopaedic Science / Issue 6/2011
Print ISSN: 0949-2658
Electronic ISSN: 1436-2023
DOI
https://doi.org/10.1007/s00776-011-0072-0

Other articles of this Issue 6/2011

Journal of Orthopaedic Science 6/2011 Go to the issue